Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial

NCT02305134 is registered in ClinicalTrials.gov with Chiba University as lead sponsor.

NCT NCT02305134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02305134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial
Lead sponsor
Chiba University
Phase
Phase 1/2
Overall status
Completed
Start date
June 11, 2015
Completion date
March 31, 2019
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit and disruptive behavior disorders, attention deficit disorder with hyperactivity disease, hyperkinesis